Brief Report: Remission Rates With Tofacitinib Treatment in Rheumatoid Arthritis: A Comparison of Various Remission Criteria

OBJECTIVE: Tofacitinib is an oral JAK inhibitor that is used for the treatment of rheumatoid arthritis (RA). In previous clinical trials of tofacitinib, a Disease Activity Score in 28 joints (DAS28)–based analysis was used to assess outcomes. In this study, remission rates according to various remis...

全面介紹

Na minha lista:
書目詳細資料
發表在:Arthritis Rheumatol
Main Authors: Smolen, Josef S., Aletaha, Daniel, Gruben, David, Zwillich, Samuel H., Krishnaswami, Sriram, Mebus, Charles
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2017
主題:
Rheumatoid Arthritis
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5396306/
https://ncbi.nlm.nih.gov/pubmed/27907269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39996
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍